FXTAS presenting with cervical dystonia as the initial symptom: Considering FXTAS in the clinical evaluation of cervical dystonia [PDF]
FXTAS (Fragile X-associated tremor/ataxia syndrome) is characterized by typical clinical features, including tremor, cerebellar ataxia, parkinsonism, and the middle cerebellar peduncle (MCP) sign, which appears as T2 hyperintensity in the MCP on MRI ...
Homare Funasaka +2 more
doaj +4 more sources
Glymphatic dysfunction and neuroinflammation in FXTAS: evidence from DTI-ALPS and gene expression analysis [PDF]
Background and objectivesFragile X–associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder that affects carriers of the FMR1 premutation (55–200 CGG repeats). It is characterized by motor and cognitive impairments.
Andrea Elias-Mas +24 more
doaj +2 more sources
T2-FLAIR hyperintensities in the inferior cerebellar peduncles and their association with clinical symptoms, molecular and MRI markers in male FMR1 premutation carriers [PDF]
Background and objectivesFMR1 premutation carriers (55–200 CGG repeats) are at risk of developing fragile X-associated tremor/ataxia syndrome (FXTAS), a neurodegenerative disorder associated with motor and cognitive impairment. Bilateral hyperintensities
Andrea Elias-Mas +16 more
doaj +2 more sources
DNA methylation and proteomic profiling of postmortem brain tissue reveals epigenetic dysregulation and inflammatory signaling in fragile X-associated tremor/ataxia syndrome [PDF]
BackgroundFragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by a CGG repeat expansion in the premutation range of FMR1. The epigenetic landscape of the FXTAS brain remains largely uncharacterized.
Reymundo Lozano +14 more
doaj +2 more sources
The apolipoprotein gene: a modulating role on brain volume and cognitive function in carriers of the fragile X premutation [PDF]
Fragile X-associated tremor/ataxia syndrome (FXTAS), caused by the FMR1 premutation allele, is associated with brain degeneration, yet the mechanisms behind this neurodegeneration still need to be elucidated.
Poonnada Jiraanont +7 more
doaj +2 more sources
Middle Cerebellar Peduncle Width—A Novel MRI Biomarker for FXTAS?
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a severe neurodegenerative movement disorder affecting over 40% of male and 16% of female FMR1 premutation carriers over the age of 50.
Randi J. Hagerman +2 more
exaly +3 more sources
Integrated multi-omics profiling reveals novel molecular biomarkers and pathways associated with Fragile X-associated tremor/ataxia syndrome [PDF]
IntroductionFragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting carriers of premutation expansions (55–200 CGG repeats) in the fragile X messenger ribonucleoprotein 1 (FMR1) gene.
Marwa Zafarullah +9 more
doaj +2 more sources
New Observations in the Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Phenotype
Purpose: Fragile X-associated tremor/ataxia syndrome (FXTAS) was originally defined as tremor, ataxia, cognitive decline and parkinsonism in individuals who carry between 55-200 CGG repeats in the promoter region of the fragile X mental retardation 1 ...
Elizabeth Berry-Kravis +2 more
exaly +3 more sources
Biomarkers of balance and gait deficits in FMR1 premutation carriers: a mini-review [PDF]
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by a premutation (PM) of the FMR1 gene on the X chromosome. FXTAS is characterized by intention tremor, ataxia, and cognitive decline.
Leila C. Moore +3 more
doaj +2 more sources
Comprehensive, multidisciplinary care for fragile X-associated tremor/ataxia syndrome [PDF]
ObjectiveThe authors reviewed the pathophysiology, clinical genetics, phenotype, and comprehensive clinical management of Fragile X-associated Tremor/Ataxia Syndrome (FXTAS), a neurodegenerative disorder affecting FMR1 premutation carriers (55–200 CCG ...
James A. Bourgeois +7 more
doaj +2 more sources

